Cornely OA - Search Results

1

Reimbursement of innovative pharmaceuticals in English and Spanish hospitals-The example of isavuconazole.

Jeck J, Wingen-Heimann SM, Thielscher C, Kron A, Bonn J, Jakobs F, Grau S, Enoch DA, Micallef C, Cornely OA, Kron F. Jeck J, et al. Among authors: cornely oa. Mycoses. 2021 Oct;64(10):1213-1222. doi: 10.1111/myc.13336. Epub 2021 Jul 1. Mycoses. 2021. PMID: 34134179

2

Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation.

Vehreschild JJ, Krüger K, Kurzai O, Wickenhauser C, Behringer K, Töx U, Cornely OA. Vehreschild JJ, et al. Among authors: cornely oa. Mycoses. 2006;49 Suppl 1:42-7. doi: 10.1111/j.1439-0507.2006.01302.x. Mycoses. 2006. PMID: 16961582

3

Antifungal treatment strategies in high risk patients.

Rüping MJ, Vehreschild JJ, Cornely OA. Rüping MJ, et al. Among authors: cornely oa. Mycoses. 2008 Sep;51 Suppl 2:46-51. doi: 10.1111/j.1439-0507.2008.01572.x. Mycoses. 2008. PMID: 18721331

4

Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals.

Rieger CT, Cornely OA, Hoppe-Tichy T, Kiehl M, Knoth H, Thalheimer M, Schuler U, Ullmann AJ, Ehlken B, Ostermann H. Rieger CT, et al. Among authors: cornely oa. Mycoses. 2012 Nov;55(6):514-20. doi: 10.1111/j.1439-0507.2012.02193.x. Epub 2012 Apr 3. Mycoses. 2012. PMID: 22471310

5

Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.

Cornely OA, Vazquez J, De Waele J, Betts R, Rotstein C, Nucci M, Pappas PG, Ullmann AJ. Cornely OA, et al. Mycoses. 2014 Feb;57(2):79-89. doi: 10.1111/myc.12104. Epub 2013 Jun 20. Mycoses. 2014. PMID: 23786573

6

Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis.

Heimann SM, Cornely OA, Vehreschild MJ, Glossmann J, Kochanek M, Kreuzer KA, Hallek M, Vehreschild JJ. Heimann SM, et al. Among authors: cornely oa. Mycoses. 2014 Feb;57(2):90-7. doi: 10.1111/myc.12105. Epub 2013 Jun 24. Mycoses. 2014. PMID: 23790060 Free article.

7

Chronic pulmonary aspergillosis.

Schweer KE, Bangard C, Hekmat K, Cornely OA. Schweer KE, et al. Among authors: cornely oa. Mycoses. 2014 May;57(5):257-70. doi: 10.1111/myc.12152. Epub 2013 Dec 2. Mycoses. 2014. PMID: 24299422 Review.

8

Our 2014 approach to mucormycosis.

Tacke D, Koehler P, Markiefka B, Cornely OA. Tacke D, et al. Among authors: cornely oa. Mycoses. 2014 Sep;57(9):519-24. doi: 10.1111/myc.12203. Epub 2014 May 15. Mycoses. 2014. PMID: 24829170 Review.

9

Our 2014 approach to candidaemia.

Koehler P, Tacke D, Cornely OA. Koehler P, et al. Among authors: cornely oa. Mycoses. 2014 Oct;57(10):581-3. doi: 10.1111/myc.12207. Epub 2014 May 26. Mycoses. 2014. PMID: 24863378 Review.

10

A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation.

Heimann SM, Vehreschild MJ, Cornely OA, Franke B, von Bergwelt-Baildon M, Wisplinghoff H, Kron F, Scheid C, Vehreschild JJ. Heimann SM, et al. Among authors: cornely oa. Eur J Haematol. 2015 Jun;94(6):526-31. doi: 10.1111/ejh.12466. Epub 2015 Feb 23. Eur J Haematol. 2015. PMID: 25310918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

631 results

Search Page